The treatment of children with non-migrainous headaches;Tratamiento de los niños con cefaleas no migrañosas

Revista de Neurologia

Volumn 37, Issue 3, 2003, Pages 281-286

  García Méndez, Leonardo ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Building C ^*  (United States)

Author keywords

Caffeine; Children; Headaches; Mechanisms; Migrainous headaches; Non migrainous headaches; Pain; Treatment

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIEMETIC AGENT; CAFFEINE; CYPROHEPTADINE; ERGOTAMINE; PROPRANOLOL; SEDATIVE AGENT;

CHILD CARE; CLINICAL EXAMINATION; CONFERENCE PAPER; DIET THERAPY; DRUG CHOICE; HEADACHE; HUMAN; PAIN ASSESSMENT; RECURRENT DISEASE; RISK FACTOR; SYNDROME DELINEATION;

EID: 17644444469     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3703.2003141     Document Type: Conference Paper

References (36)

1. Jay GW, Tomasi LG. Pediatric headaches: a one year retrospective analysis. Headache 1981; 21: 5-9.
2. Bille BS. Migraine in school children. Acta Paediatr Scand 1962; 51 (Suppl 136): 1-151.
3. Starfield B, Katz H, Gabriel A, Livingston G, Benson P, Hankin J, et al. Morbidity in childhood: a longitudinal view. N Engl J Med 1984; 310: 824-9.
4. Wolff HJ, Dalessio DJ. Pain-sensitive structures within the cranium. In Dalessio DE, Wolff HJ, eds. Headaches and other related head pains. 4 ed. Oxford University Press; 1980: 24-55.
5. Welch KMA, D'Andrea G, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clinics 1990; 8: 817-28.
6. Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002; 59: 490-8.
7. Kandt RS, Levine RM. Headache and acute illness in children. J Child Neurol 1987; 2: 22-7.
8. Raskin NH. Lumbar puncture headache: a review. Headache 1990; 30: 197-200.
9. Edwards RJ, Pople IK. Side-effects of risperidone therapy mimicking cerebrospinal fluid shunt malfunction: implications for clinical monitoring and management. J Psychopharmacol 2002; 16: 177-9.
10. Lanzi G, Ballotin U, Borgatti R, De Agostini G, Pezzotta S, Spanu G. Late post-traumatic headache in pediatric age. Cephalalgia 1985; 5: 211-5.
11. Kandt RS, Goldstein GW. Steroid responsive ophtalmoplegia in a child. Diagnostic consideration. Arch Neurol 1985; 42: 589.
12. Dugan MC, Lock S, Gallagher JR. Occipital neuralgia in adolescents and young adults. N Engl J Med 1962; 267: 1166-72.
13. Curless RG. Cluster headaches in childhood. J Pediatr 1982; 101: 393-5.
14. Rothner AD. Diagnosis and management of headache in children and adolescents. Neurol Clin 1983; 1: 511-6.
15. Rothner AD. Headaches in children and adolescents. Clin J Pain 1989; 5: 67-75.
16. Abu-Arafeh I. Chronic tension-type headache in children and adolescents. Cephalalgia 2001; 21: 830-6
17. Rothner AD. Headaches in children: a review. Headache 1978; 18: 169-75.
18. Ford RJ, Ford KT. Thermography in the diagnosis of headache. Semin Neurol 1997; 17: 343-9.
19. Diamond S. Biofeedback and headache. Headache 1979; 19: 180-4.
20. Shinnar S. An approach to the child with headaches. Int Pediatr 1991; 6: 140-8.
21. Garcia L, Papazian O. Headaches: home remedy therapy. Int Pediatr 1987; 2: 129-34.
22. Dexter DJ, Roberts J, Byer JA. The five hour glucose tolerance test and effect of low sucrose diet in migraine. Headache 1978; 18: 91-5.
23. Barlow CF. Headaches and migraine in childhood. Oxford: Blackwell Scientific Publications; 1984.
24. Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A. Caffeine as an analgesic adjuvant. JAMA 1984; 251: 1711-8.
25. Ward N, Whitney C, Avery D, Dunner D. The analgesic effects of caffeine in headache. Pain 1991; 44: 151-5.
26. Rail TW. Evolution of the mechanisms of action of methylxantines from calcium movilizers to antagonist of adenosine receptors. Pharmacologist 1982; 241: 277-88.
27. Snyder SH, Sklar P. Behavioral and molecular actions of caffeine: focus on adenosine. J Psychiat Res 1984; 18: 91-106.
28. Rail TW. Central nervous system stimulants. The methylxantines. In Gilman AG, et al, eds. The pharmacological basis of therapeutics. New York: MacMillan Publishing; 1985. p. 589-603.
29. Cheraskin E, Ringsdorf WM, Setyaadmadja ATS, Barrett RA. Effect of caffeine versus placebo supplementation on blood-glucose concentration. The Lancet 1967; 6: 1299-300.
30. Gelmers HJ. Calcium-channel blockers in the treatment of migraine. Am J Cardiol 1985; 55: 139-43.
31. Mathew RJ, Wilson WH. Caffeine consumption, withdrawal and cerebral blood flow. Headache. 1985; 25: 305-9.
32. Pinessi L, Piazza D, Vaula G, Rainero I, De Gennaro T, Bergamasco B, et al. Beta-endorfina plasmatica e consume di caffeina nel hemicrania cronicizzata. Minerva Med 1990; 81: 691-5.
33. Nappi G, Facchinetti F, Martignoni E, Petraglia F, Bono G, Micieli G, et al. Plasma and CSF endorphin levels in primary and symptomatic headaches. Headache 1985; 25: 141-4.
34. Fettes I, Gawel M, Kusniak S, Edmeads J. Endorphin levels in headache syndromes. Headache. 1985; 25: 37-9.
35. García-Méndez L. Los dolores de cabeza en los niños. Guía práctica informativa para padres, maestros y personal paramédico. Maracaibo: Lemar; 1988.
36. García-Méndez L. Headaches in children. Practical informative guide for parents, teachers and paramedical personnel. Columbia, MO: Lemar Publishers; 1996.